These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 34694581)

  • 1. Hepatocellular carcinoma patients with portal vein thrombosis treated with robotic radiosurgery: Interim results of a prospective study.
    Dutta D; Tatineni T; Yarlagadda S; Gupte A; Reddy SK; Madhavan R; Nair H; Sasidharan A; Kannan R; Pottayil SG; Holla R; Sudhindran S
    Indian J Gastroenterol; 2021 Aug; 40(4):389-401. PubMed ID: 34694581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-relation of Portal Vein Tumour Thrombus Response With Survival Function Following Robotic Radiosurgery in Vascular Invasive Hepatocellular Carcinoma.
    Dutta D; Yarlagadda S; Kalavagunta S; Nair H; Sasidharan A; Nimmya SK; Kannan R; George S; Edappattu A; Haridas NK; Jose WM; Keechilat P; Valsan A; Koshy A; Gopalakrishna R; Sadasivan S; Gopalakrishnan U; Balakrishnan D; Sudheer OV; Surendran S
    J Clin Exp Hepatol; 2024; 14(5):101404. PubMed ID: 38680618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereotactic body radiotherapy based treatment for hepatocellular carcinoma with extensive portal vein tumor thrombosis.
    Shui Y; Yu W; Ren X; Guo Y; Xu J; Ma T; Zhang B; Wu J; Li Q; Hu Q; Shen L; Bai X; Liang T; Wei Q
    Radiat Oncol; 2018 Sep; 13(1):188. PubMed ID: 30253783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of stereotactic body radiotherapy for portal vein tumor thrombosis in patients with hepatocellular carcinoma and underlying chronic liver disease.
    Choi HS; Kang KM; Jeong BK; Jeong H; Lee YH; Ha IB; Song JH
    Asia Pac J Clin Oncol; 2021 Jun; 17(3):209-215. PubMed ID: 32757461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined stereotactic body radiotherapy and trans-arterial chemoembolization as initial treatment in BCLC stage B-C hepatocellular carcinoma.
    Chiang CL; Chan MKH; Yeung CSY; Ho CHM; Lee FAS; Lee VWY; Wong FCS; Blanck O
    Strahlenther Onkol; 2019 Mar; 195(3):254-264. PubMed ID: 30413833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Objective Tumor Response of Hepatocellular Carcinoma Obtained by Transarterial Radioembolization with Iodine-131-Lipiodol Versus Transarterial Chemoembolization for Patients with and without Portal Venous Thrombosis: A Controlled Interventional Trial.
    Oliveira Ribeiro MC; Moda KA; Alvarez M; Koga KH; Moriguchi SM; Carvalho FC; Pinheiro RSN; Qi X; Romeiro FG
    Acad Radiol; 2024 May; 31(5):1839-1848. PubMed ID: 38016824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-dimensional conformal radiotherapy for portal vein thrombosis of hepatocellular carcinoma.
    Kim DY; Park W; Lim DH; Lee JH; Yoo BC; Paik SW; Kho KC; Kim TH; Ahn YC; Huh SJ
    Cancer; 2005 Jun; 103(11):2419-26. PubMed ID: 15822130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of transarterial chemoembolization in Egyptian patients with hepatocellular carcinoma and branch portal vein thrombosis.
    Abdella H; Shaker MK; Montasser IF; Sobhi M; Aly H; Sayed A; Saleh S; El Dorry A
    Indian J Gastroenterol; 2018 Mar; 37(2):127-132. PubMed ID: 29532323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transarterial chemoembolization in hepatocellular carcinoma with portal vein tumor thrombosis: a systematic review and meta-analysis.
    Silva JP; Berger NG; Tsai S; Christians KK; Clarke CN; Mogal H; White S; Rilling W; Gamblin TC
    HPB (Oxford); 2017 Aug; 19(8):659-666. PubMed ID: 28552299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thermal Ablation Versus Stereotactic Body Radiotherapy After Transarterial Chemoembolization for Inoperable Hepatocellular Carcinoma: A Propensity Score-Weighted Analysis.
    Nabavizadeh N; Jahangiri Y; Rahmani R; Tomozawa Y; Geeratikun Y; Chen Y; Hung A; Degnin C; Farsad K
    AJR Am J Roentgenol; 2021 Sep; 217(3):691-698. PubMed ID: 32997517
    [No Abstract]   [Full Text] [Related]  

  • 11. Yttrium-90 trans-arterial radioembolization in advanced-stage HCC: The impact of portal vein thrombosis on survival.
    Somma F; Stoia V; Serra N; D'Angelo R; Gatta G; Fiore F
    PLoS One; 2019; 14(5):e0216935. PubMed ID: 31141552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Favorable survival time provided with radioembolization in hepatocellular carcinoma patients with and without portal vein thrombosis.
    Ozkan ZG; Poyanli A; Ucar A; Kuyumcu S; Akyuz F; Keskin S; Saglam S; Yilmaz E; Karaca C; Turkmen C
    Cancer Biother Radiopharm; 2015 Apr; 30(3):132-8. PubMed ID: 25760644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microwave ablation of hepatocellular carcinoma with portal vein tumor thrombosis after transarterial chemoembolization: a prospective study.
    Long J; Zheng JS; Sun B; Lu N
    Hepatol Int; 2016 Jan; 10(1):175-84. PubMed ID: 26742761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transarterial chemoembolization of hepatocellular carcinoma with segmental portal vein tumour thrombus.
    Choi JW; Kim HC; Lee JH; Yu SJ; Kim YJ; Yoon JH; Jae HJ; Hur S; Lee M; Chung JW
    Eur Radiol; 2017 Apr; 27(4):1448-1458. PubMed ID: 27516356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined endovascular brachytherapy, sorafenib, and transarterial chemobolization therapy for hepatocellular carcinoma patients with portal vein tumor thrombus.
    Zhang ZH; Liu QX; Zhang W; Ma JQ; Wang JH; Luo JJ; Liu LX; Yan ZP
    World J Gastroenterol; 2017 Nov; 23(43):7735-7745. PubMed ID: 29209114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioembolization vs sorafenib in locally advanced hepatocellular carcinoma with portal vein tumor thrombosis: A propensity score and Bayesian analysis.
    Martelletti C; Ricotti A; Gesualdo M; Carucci P; Gaia S; Rolle E; Burlone ME; Okolicsanyi S; Mattalia A; Pirisi M; Berchialla P; Tabone M
    J Dig Dis; 2021 Aug; 22(8):496-502. PubMed ID: 34189839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of stereotactic body radiation therapy with and without sorafenib as treatment for hepatocellular carcinoma with portal vein tumor thrombosis.
    Que J; Wu HC; Lin CH; Huang CI; Li LC; Ho CH
    Medicine (Baltimore); 2020 Mar; 99(13):e19660. PubMed ID: 32221093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Portal vein thrombosis and arterioportal shunts: effects on tumor response after chemoembolization of hepatocellular carcinoma.
    Vogl TJ; Nour-Eldin NE; Emad-Eldin S; Naguib NN; Trojan J; Ackermann H; Abdelaziz O
    World J Gastroenterol; 2011 Mar; 17(10):1267-75. PubMed ID: 21455325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined Chemoembolization and Radiotherapy Versus Chemoembolization Alone for Hepatocellular Carcinoma Invading the Hepatic Vein or Inferior Vena Cava.
    Alrashidi I; Chu HH; Kim JH; Shim JH; Yoon SM; Kim PH; Gwon DI; Ko HK
    Cardiovasc Intervent Radiol; 2021 Jul; 44(7):1060-1069. PubMed ID: 33745071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience With LDLT in Patients With Hepatocellular Carcinoma and Portal Vein Tumor Thrombosis Postdownstaging.
    Soin AS; Bhangui P; Kataria T; Baijal SS; Piplani T; Gautam D; Choudhary NS; Thiagarajan S; Rastogi A; Saraf N; Saigal S
    Transplantation; 2020 Nov; 104(11):2334-2345. PubMed ID: 32032291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.